400+

Employees

50+

Fortune 500 Clients

$5M+

Life Time Value per Client

$15M

Revenue in 2021

Invest in
PromiCell Today

PromiCell is revolutionizing cancer care with cutting-edge T-cell therapies targeting high-value markets. With exclusive partnerships with world-class institutions like FH and MSK, and multiple clinical-stage programs, now is the time to invest in a clinical-stage biotech poised for exponential growth and life-changing impact.

Exclusive Partnerships: